Skip to main content

Table 1 Demographic and Baseline Clinical Characteristics of Patients

From: Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

Variables

Patients N. (N = 80)

Sex

 Male

50 (62.5%)

 Female

30 (37.5%)

Age

 Median (range)

50 (24–75)

 < 50

39 (48.8%)

 ≥ 50

41 (51.2%)

Extant of surgery

  Partial resection

44 (55.0%)

 Complete resection

36 (45.0%)

Concurrent TMZ

 Yes

75 (93.8%)

 No

5 (6.2%)

KPS scores

 90–100

41 (51.2%)

 80

16 (20.0%)

  ≤ 70

23 (28.8%)

TMZ cycles

 Median (range)

5 (0–12)

 < 6

42 (52.5%)

 ≥ 6

38 (47.5%)